QUALIGEN THERAPEUTICS INC (QLGN) Stock Income Statement
NASDAQ:QLGN - Nasdaq - US74754R3012 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 4.98M | 5.65M | 2.85M | 0.00 | |||
| Minority Interest Expense | N/A | 2.39M | N/A | N/A | N/A | |||
| Cost Of Goods | N/A | 4.30M | 4.33M | 2.64M | N/A | |||
| Gross Profit | N/A | 680.00K | 1.32M | 210.00K | N/A | |||
| Operating Expenses | 11.30M | 18.62M | 23.99M | 10.73M | 10.84M | |||
| Research and Development | 5.21M | 6.84M | 11.72M | 3.32M | 6.13M | |||
| Selling, General, and Administrative Expenses | 6.10M | 11.79M | 12.27M | 7.41M | 4.57M | |||
| Operating Income | -11.30M | -17.94M | -22.66M | -10.52M | -10.84M | |||
| Interest Income/Expense | -1.52M | -30.00K | 40.00K | -50.00K | 120.00K | |||
| Other Income/Expense | 2.07M | 910.00K | 4.73M | -8.05M | 590.00K | |||
| Non Recurring Items | -1.70M | -4.24M | N/A | -920.00K | N/A | |||
| Income Before Taxes | -12.48M | -21.30M | -17.89M | -19.55M | -10.13M | |||
| Income Tax | -4.80K | -270.00K | 10.00K | 0.00 | N/A | |||
| Net Income | -13.42M | -18.64M | -17.90M | -19.55M | -10.13M | |||
| EBITDA | -11.30M | -17.79M | -22.55M | -10.43M | -10.83M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -132.25 | -4.85 | -6.10 | -11.23 | -253.25 | |||
| Non GAAP EPS | N/A | N/A | -6.10 | N/A | -289.50 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | 13.65% | 23.36% | 7.37% | N/A | |||
| Profit Margin | N/A | -374.30% | -316.81% | -685.96% | N/A | |||
| Operating Profit Margin | N/A | -360.24% | -401.06% | -369.12% | N/A | |||
All data in USD